Margaret Callahan
MD PhD
Medical Oncologist
👥Biography 个人简介
Margaret Callahan at MSK has contributed to the clinical development and mechanistic understanding of combined checkpoint blockade (anti-PD-1 plus anti-CTLA-4). Her contributions to CheckMate-067 and related studies demonstrating superior outcomes with ipilimumab-nivolumab versus monotherapy in melanoma, and her research on the mechanisms and biomarkers of response and toxicity to combination checkpoint blockade, have been important for this transformative treatment approach.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Margaret Callahan 的研究动态
Follow Margaret Callahan's research updates
留下邮箱，当我们发布与 Margaret Callahan（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment